Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Nov;104(5):1008-1017.
doi: 10.1016/j.kint.2023.07.022. Epub 2023 Aug 19.

Association of HIV and viral suppression status with hospital acute kidney injury in the era of antiretroviral therapy

Affiliations
Observational Study

Association of HIV and viral suppression status with hospital acute kidney injury in the era of antiretroviral therapy

Molly C Fisher et al. Kidney Int. 2023 Nov.

Abstract

In the modern era, it is unknown if people that are virally suppressed with HIV (PWH) are at increased risk for acute kidney injury (AKI) compared to people without HIV and no studies have compared the risk of AKI by viral suppression status. Here, we determined the associations of HIV status and AKI among PWH with and without viral suppression compared to people without HIV. An observational cohort study of PWH and people without HIV hospitalized in a large New York City health system between 2010-2019 was conducted. Multivariable Cox proportional hazards models were used to determine associations between HIV status and risk of AKI, severe AKI and development of chronic kidney disease (CKD). Among 173,884 hospitalized patients, 4,718 had HIV; 2,532 (53.7%) were virally suppressed and 2,186 (46.3%) were not suppressed. Compared to people without HIV, PWH with and without viral suppression were at increased risk of AKI (adjusted hazard ratio 1.27, 95% confidence interval 1.15, 1.40 and 1.73, 1.58, 1.90, respectively) and AKI requiring kidney replacement therapy (1.89, 1.27, 2.84 and 1.87, 1.23, 2.84, respectively). Incremental, graded associations were observed between HIV status and Stage 2 or 3 AKI, and among AKI survivors, and incident CKD. The elevated risk of AKI across ages of PWH was similar in magnitude to older people without HIV. Thus, regardless of virologic control, HIV is an independent risk factor for AKI among hospitalized patients. Future studies should determine the mechanisms by which HIV increases susceptibility to AKI and identify strategies to prevent AKI in PWH.

Keywords: HIV; acute kidney injury; hospital; outcomes.

PubMed Disclaimer

Figures

Figure 1 |
Figure 1 |. Flowchart of the study population.
AKI, acute kidney injury; ART, antiretroviral therapy; MMC, Montefiore Medical Center.
Figure 2 |
Figure 2 |. Independent factors associated with hospital acute kidney injury.
Data adjusted for age, sex, Black race, chronic kidney disease (CKD), diabetes, hypertension, hyperlipidemia, cardiovascular disease, hepatitis C infection, pulmonary disease, intensive care unit (ICU) admission, and prescription for angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, nonsteroidal anti-inflammatory drug, or tenofovir disoproxil fumarate. Adjusted hazard ratios (aHRs) (95% confidence intervals [CIs]) are as follows: HIV(+) suppressed, 1.27 (1.15–1.40); HIV(+) unsuppressed, 1.73 (1.58–1.90); female sex, 0.88 (0.86–0.90); diabetes, 1.26 (1.23–1.29); hypertension, 1.21 (1.17–1.25); cardiovascular disease, 1.11 (1.09–1.14); CKD, 1.60 (1.56–1.65); hepatitis C, 1.27 (1.20–1.34); and ICU admission, 1.58 (1.54–1.62).
Figure 3 |
Figure 3 |. Risk of hospital acute kidney injury by HIV status across age tertiles.
Data are adjusted for sex, Black race, chronic kidney disease, diabetes, hypertension, cardiovascular disease, hepatitis C infection, and intensive care unit admission. Adjusted hazard ratios (aHRs) (95% confidence intervals [CIs]) are as follows: HIV(–) for those aged <40 years, reference; HIV(–) for those aged 40 to 59 years, 1.27 (1.22–1.33); HIV(–) for those aged ≥60 years, 1.63 (1.57–1.70); HIV(+) for those aged <40 years, 1.82 (1.60–2.07); HIV(+) for those aged 40 to 59 years, 1.80 (1.65–1.97); and HIV(+) for those aged ≥60 years, 1.84 (1.58–2.15).

References

    1. United Nations Programme on HIV and AIDS. Global HIV & AIDS statistics – fact sheet. Accessed March 10, 2023. https://www.unaids.org/en/resources/fact-sheet
    1. Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4:e349–e356. - PMC - PubMed
    1. Edwards JK, Cole SR, Breger TL, et al. Mortality among persons entering HIV care compared with the general U.S. population: an observational study. Ann Intern Med. 2021;174:1197–1206. - PMC - PubMed
    1. Collins LF, Sheth AN, Mehta CC, et al. The prevalence and burden of non-AIDS comorbidities among women living with or at risk for human immunodeficiency virus infection in the United States. Clin Infect Dis. 2021;72:1301–1311. - PMC - PubMed
    1. Pelchen-Matthews A, Ryom L, Borges AH, et al. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort. AIDS. 2018;32:2405–2416. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources